Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,221 | 1,413 | 98.5% |
| Education | $331.68 | 17 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,741 | 101 | $0 (2024) |
| Novo Nordisk Inc | $2,465 | 208 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,970 | 155 | $0 (2024) |
| ABBVIE INC. | $1,420 | 97 | $0 (2024) |
| PFIZER INC. | $1,211 | 100 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,176 | 106 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $834.12 | 47 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $770.25 | 23 | $0 (2021) |
| Lilly USA, LLC | $735.11 | 93 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $641.84 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,177 | 135 | ABBVIE INC. ($426.48) |
| 2023 | $2,218 | 141 | ABBVIE INC. ($412.10) |
| 2022 | $2,302 | 156 | AstraZeneca Pharmaceuticals LP ($295.81) |
| 2021 | $3,014 | 186 | Biohaven Pharmaceuticals, Inc. ($544.14) |
| 2020 | $2,683 | 192 | GlaxoSmithKline, LLC. ($356.97) |
| 2019 | $2,595 | 209 | AstraZeneca Pharmaceuticals LP ($357.70) |
| 2018 | $2,866 | 207 | AstraZeneca Pharmaceuticals LP ($744.20) |
| 2017 | $3,698 | 204 | GlaxoSmithKline, LLC. ($392.92) |
All Payment Transactions
1,430 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Obesity | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $1.30 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Obesity | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 53 | 3,224 | 5,033 | $467,487 | $179,118 |
| 2022 | 57 | 3,533 | 5,205 | $484,844 | $182,198 |
| 2021 | 62 | 3,414 | 6,751 | $441,657 | $162,641 |
| 2020 | 55 | 3,212 | 4,749 | $400,544 | $132,115 |
All Medicare Procedures & Services
227 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 248 | 576 | $115,200 | $45,067 | 39.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 86 | 501 | $50,100 | $22,609 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 164 | 164 | $26,240 | $19,652 | 74.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 148 | $40,700 | $17,666 | 43.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 205 | 206 | $38,110 | $14,328 | 37.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 68 | 299 | $26,910 | $10,282 | 38.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 173 | 173 | $8,650 | $2,877 | 33.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 210 | 281 | $14,050 | $2,865 | 20.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $3,850 | $2,819 | 73.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $4,800 | $2,470 | 51.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 155 | 171 | $9,576 | $2,230 | 23.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 78 | 79 | $2,765 | $2,218 | 80.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 157 | 225 | $10,575 | $2,116 | 20.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 201 | 269 | $9,146 | $2,004 | 21.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 81 | 113 | $7,684 | $1,860 | 24.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 83 | 84 | $2,520 | $1,725 | 68.5% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 18 | 18 | $6,390 | $1,684 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 132 | 195 | $2,700 | $1,566 | 58.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 156 | $5,460 | $1,558 | 28.5% |
| 77067 | Screening mammography | Office | 2023 | 19 | 19 | $6,555 | $1,513 | 23.1% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 15 | $3,525 | $1,493 | 42.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 76 | 78 | $4,836 | $1,406 | 29.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 46 | 46 | $9,430 | $1,196 | 12.7% |
| 84681 | C-peptide (protein) level | Office | 2023 | 48 | 59 | $3,835 | $1,183 | 30.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,340 | $1,076 | 24.8% |
About Rajkamal Harricharan Singh
Rajkamal Harricharan Singh is a Family Medicine healthcare provider based in Newport, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2012. The National Provider Identifier (NPI) number assigned to this provider is 1891054540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rajkamal Harricharan Singh has received a total of $21,552 in payments from pharmaceutical and medical device companies, with $2,177 received in 2024. These payments were reported across 1,430 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($21,221).
As a Medicare-enrolled provider, Harricharan Singh has provided services to 13,383 Medicare beneficiaries, totaling 21,738 services with total Medicare billing of $656,073. Data is available for 4 years (2020–2023), covering 227 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Family Medicine
- Location Newport, TN
- Active Since 05/15/2012
- Last Updated 02/09/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1891054540
Products in Payments
- Ozempic (Drug) $1,132
- FARXIGA (Drug) $1,083
- VRAYLAR (Drug) $1,001
- TRELEGY ELLIPTA (Drug) $976.72
- NURTEC ODT (Drug) $924.74
- JARDIANCE (Drug) $823.41
- ENTRESTO (Drug) $641.84
- REXULTI (Drug) $611.92
- XARELTO (Drug) $544.29
- SYMBICORT (Drug) $402.31
- ANORO (Drug) $386.21
- Rybelsus (Drug) $365.59
- TRULICITY (Drug) $358.85
- XIFAXAN (Drug) $351.31
- ELIQUIS (Drug) $343.93
- UBRELVY (Drug) $324.52
- Wegovy (Drug) $308.36
- BREZTRI (Drug) $305.65
- BEVESPI AEROSPHERE (Drug) $297.89
- CHANTIX (Drug) $292.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Newport
Albert Knouse, Md, MD
Family Medicine — Payments: $102,367
Dr. Clayton Kersting, M.d, M.D
Family Medicine — Payments: $35,414
Catherine Spiker, D.o, D.O
Family Medicine — Payments: $22,819
Mr. Michael Hood, Md, MD
Family Medicine — Payments: $19,457
Karl Sitterly, M.d, M.D
Family Medicine — Payments: $16,066
Dr. David Kickliter, Md, MD
Family Medicine — Payments: $12,702